Circa 2017
Insulin-producing cells have been restored in mouse models of type 1 diabetes using a new genetic engineering technique.
American scientists adapted the gene editing technology known as CRISPR (clustered, regularly interspaced, short palindromic repeat) to successfully treat mouse models of type 1 diabetes, kidney disease and muscular dystrophy.
CRISPR enables scientists to edit the genetic material of an organism allowing for DNA sequences to be easily altered and gene function to be modified.
Comments are closed.